Nicolas Willand

2.0k total citations
58 papers, 1.2k citations indexed

About

Nicolas Willand is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Nicolas Willand has authored 58 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 22 papers in Organic Chemistry and 19 papers in Infectious Diseases. Recurrent topics in Nicolas Willand's work include Cancer therapeutics and mechanisms (19 papers), Tuberculosis Research and Epidemiology (18 papers) and Biochemical and Molecular Research (12 papers). Nicolas Willand is often cited by papers focused on Cancer therapeutics and mechanisms (19 papers), Tuberculosis Research and Epidemiology (18 papers) and Biochemical and Molecular Research (12 papers). Nicolas Willand collaborates with scholars based in France, Belgium and United States. Nicolas Willand's co-authors include Benoît Déprez, Alain R. Baulard, Marion Flipo, Baptiste Villemagne, Rebecca Deprez‐Poulain, Céline Crauste, Florence Leroux, Vincent Villeret, Priscille Brodin and Terence Beghyn and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Nicolas Willand

55 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolas Willand France 20 606 411 408 193 134 58 1.2k
Marco Pieroni Italy 23 771 1.3× 493 1.2× 683 1.7× 332 1.7× 92 0.7× 58 1.6k
Marion Flipo France 18 501 0.8× 299 0.7× 251 0.6× 158 0.8× 93 0.7× 30 962
Giovanna Poce Italy 24 652 1.1× 634 1.5× 745 1.8× 421 2.2× 113 0.8× 54 1.7k
Thierry Masquelin United States 23 510 0.8× 344 0.8× 579 1.4× 198 1.0× 95 0.7× 39 1.2k
Vincent Delorme France 19 482 0.8× 452 1.1× 148 0.4× 300 1.6× 58 0.4× 32 1.0k
Christopher B. Cooper United States 21 684 1.1× 522 1.3× 502 1.2× 287 1.5× 107 0.8× 47 1.3k
Vinayak Singh South Africa 21 559 0.9× 518 1.3× 263 0.6× 250 1.3× 101 0.8× 51 1.1k
Adrian Blaser New Zealand 22 708 1.2× 465 1.1× 599 1.5× 283 1.5× 93 0.7× 30 1.3k
Garrett C. Moraski United States 23 753 1.2× 597 1.5× 774 1.9× 298 1.5× 87 0.6× 35 1.6k
Arnaldo Fravolini Italy 22 789 1.3× 339 0.8× 670 1.6× 175 0.9× 124 0.9× 70 1.6k

Countries citing papers authored by Nicolas Willand

Since Specialization
Citations

This map shows the geographic impact of Nicolas Willand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Willand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Willand more than expected).

Fields of papers citing papers by Nicolas Willand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Willand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Willand. The network helps show where Nicolas Willand may publish in the future.

Co-authorship network of co-authors of Nicolas Willand

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Willand. A scholar is included among the top collaborators of Nicolas Willand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Willand. Nicolas Willand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sanz‐García, Fernando, Marie Sylvianne Rabodoarivelo, Nicolas Willand, et al.. (2024). Evaluation of critical parameters in the hollow‐fibre system for tuberculosis: A case study of moxifloxacin. British Journal of Clinical Pharmacology. 90(7). 1711–1727.
2.
Humeau, Catherine, et al.. (2024). Biocatalytic Regioselective O‐acylation of Sesquiterpene Lactones from Chicory: A Pathway to Novel Ester Derivatives. ChemBioChem. 25(6). e202300722–e202300722. 1 indexed citations
3.
Plé, Coline, Giuseppe Sicoli, Ravil R. Petrov, et al.. (2024). Small molecule MarR modulators potentiate metronidazole antibiotic activity in aerobic E. coli by inducing activation by the nitroreductase NfsA. Journal of Biological Chemistry. 300(7). 107431–107431.
4.
Landry, Valérie, Pascal Roussel, Catherine Piveteau, et al.. (2023). Regioselective and Stereoselective Synthesis of Parthenolide Analogs by Acyl Nitroso-Ene Reaction and Their Biological Evaluation against Mycobacterium tuberculosis. International Journal of Molecular Sciences. 24(24). 17395–17395. 1 indexed citations
5.
Piveteau, Catherine, Florence Leroux, Stéphanie Slupek, et al.. (2023). Exploring the Antitubercular Activity of Anthranilic Acid Derivatives: From MabA (FabG1) Inhibition to Intrabacterial Acidification. Pharmaceuticals. 16(3). 335–335. 2 indexed citations
6.
Jiménez-Castellanos, Juan-Carlos, Elizabeth Pradel, Catherine Piveteau, et al.. (2023). Optimization of pyridylpiperazine-based inhibitors of the Escherichia coli AcrAB-TolC efflux pump. European Journal of Medicinal Chemistry. 259. 115630–115630. 6 indexed citations
7.
Jiménez-Castellanos, Juan-Carlos, Laurye Van Maele, Elizabeth Pradel, et al.. (2023). Pyridylpiperazine efflux pump inhibitor boosts in vivo antibiotic efficacy against K. pneumoniae. EMBO Molecular Medicine. 16(1). 93–111. 12 indexed citations
8.
Flipo, Marion, et al.. (2023). Antibiotics with novel mode of action as new weapons to fight antimicrobial resistance. European Journal of Medicinal Chemistry. 256. 115413–115413. 24 indexed citations
9.
Jourdan, Jean‐Pierre, et al.. (2020). Desirable drug–drug interactions or when a matter of concern becomes a renewed therapeutic strategy. Drug Discovery Today. 26(2). 315–328. 12 indexed citations
10.
Kemmer, Christian, Adrien Herlédan, Rosangela Frita, et al.. (2019). A fragment-based approach towards the discovery of N-substituted tropinones as inhibitors of Mycobacterium tuberculosis transcriptional regulator EthR2. European Journal of Medicinal Chemistry. 167. 426–438. 14 indexed citations
11.
Wohlkönig, Alexandre, Sameh H. Soror, Marion Flipo, et al.. (2018). A comprehensive analysis of the protein-ligand interactions in crystal structures of Mycobacterium tuberculosis EthR. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1867(3). 248–258. 11 indexed citations
12.
Tatum, Natalie J., John W. Liebeschuetz, Jason C. Cole, et al.. (2017). New active leads for tuberculosis booster drugs by structure-based drug discovery. Organic & Biomolecular Chemistry. 15(48). 10245–10255. 20 indexed citations
13.
Pancani, Elisabetta, Samuel Jouny, Arnaud Machelart, et al.. (2017). Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles. Scientific Reports. 7(1). 5390–5390. 67 indexed citations
14.
Wohlkönig, Alexandre, Han Remaut, F. Meyer, et al.. (2017). Structural analysis of the interaction between spiroisoxazoline SMARt-420 and the Mycobacterium tuberculosis repressor EthR2. Biochemical and Biophysical Research Communications. 487(2). 403–408. 9 indexed citations
15.
Crauste, Céline, Nicolas Willand, Baptiste Villemagne, et al.. (2014). Unconventional surface plasmon resonance signals reveal quantitative inhibition of transcriptional repressor EthR by synthetic ligands. Analytical Biochemistry. 452. 54–66. 20 indexed citations
16.
Tatum, Natalie J., Baptiste Villemagne, Nicolas Willand, et al.. (2013). Structural and docking studies of potent ethionamide boosters. Acta Crystallographica Section C Crystal Structure Communications. 69(11). 1243–1250. 7 indexed citations
17.
Villemagne, Baptiste, Céline Crauste, Marion Flipo, et al.. (2012). Tuberculosis: The drug development pipeline at a glance. European Journal of Medicinal Chemistry. 51. 1–16. 136 indexed citations
18.
19.
Beghyn, Terence, Rebecca Deprez‐Poulain, Nicolas Willand, Benoı̂t Folléas, & Benoît Déprez. (2008). Natural Compounds: Leads or Ideas? Bioinspired Molecules for Drug Discovery. Chemical Biology & Drug Design. 72(1). 3–15. 67 indexed citations
20.
Critchley, Peter, et al.. (2003). Carbohydrate–protein interactions at interfaces: synthesis of thiolactosyl glycolipids and design of a working model for surface plasmon resonance. Organic & Biomolecular Chemistry. 1(6). 928–938. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marco Pieroni Breakdown of academic impact, for papers by Marion Flipo Breakdown of academic impact, for papers by Giovanna Poce Breakdown of academic impact, for papers by Thierry Masquelin Breakdown of academic impact, for papers by Vincent Delorme Breakdown of academic impact, for papers by Christopher B. Cooper Breakdown of academic impact, for papers by Vinayak Singh Breakdown of academic impact, for papers by Adrian Blaser Breakdown of academic impact, for papers by Garrett C. Moraski Breakdown of academic impact, for papers by Arnaldo Fravolini
Rankless by CCL
2026